Chief Scientist Jesse Goodman is returning to academia and had been at the FDA for 15 years. Public health was one of his main areas of responsibility. In addition, in December the FDA lost Jay Crowley to private industry who was the head of the Unique Device Identification program and had been at the agency for 27 years, a long time.
Mr. Crowley is taking a job in the private industry at USDM Life Sciences and was the Senior advisor for patient safety at the agency for devices and radiology. BD
The U.S. Food and Drug Administration's top scientist is latest high-profile figure to leave the agency tasked with protecting consumers from hazardous products.
FDA Commissioner Margaret Hamburg announced Thursday afternoon in an email to staff that chief scientist Jesse Goodman is leaving the agency to get back into academia and clinical medicine.
Goodman was a key figure at the FDA for 15 years. Hamburg called him a "strong voice" for the FDA's scientific regulatory activities.
"(Goodman) worked closely with government and industry partners to help our nation prepare for and respond to major public health threats, including bioterrorism, West Nile Virus and other threats to blood and organ safety, and both seasonal and pandemic influenza," Hamburg wrote.
Goodman is the latest top official at the FDA to leave the agency in recent months. John Taylor, counselor to the commissioner, top press officer Virginia Cox, senior adviser Jay Crowley and Deborah Autor, who was in charge of global regulations, departed as well.